The flexible camera, which Albert described as similar to a noodle, is inserted into the patient’s bile duct and can help physicians receive an enhanced view of the exact spot for biopsy, allowing for significantly improved diagnoses.
Offering an alternative to more traditional 2D x-ray imaging, it can help confirm malignant conditions such as pancreatic cancer, as well as gall and bile stones, cystic lesions and benign conditions which could become more serious without immediate treatment.
Although improving, the five-year survival rate for pancreatic cancer in Australia is currently only about 10 per cent, among the lowest of all cancers and making early detection and treatment crucial.
“There’ll always be patients not suitable for surgery for various reasons, so Spyglass can help us treat them,” said Albert.
“By helping us diagnose these conditions earlier, it can also help reduce admissions to intensive care.
“We had wonderful support from the gastrointestinal surgeons at RNSH which has helped us explore the use of Spyglass here. I’m really excited about its future uses.
“We expect this revolutionary treatment will now be permanently integrated into RNSH’s imaging and interventional service.”